Take a Tour of the IsoFlux System

Michael Schwartz, Program Director and co-founder of Fluxion Biosciences.

Wednesday, May 22, 2013


Circulating tumor cells (CTC's) have shown great promise as an easily accessed source of tumor-derived cells. If your CTC translational research efforts are long on ideas, but short on available technologies to isolate CTC's for molecular profiling, you'll want to tune in to this webinar to take a tour of the recently introduced IsoFlux system.